type here...

CATEGORIES

Clinical Trials

LATEST

123Page 3 of 3

TRENDING

EDITORS CHOICE

Covid’s Elephant in the Room. We Must Address it

Robert Turner, Founding Editor -
This article is based on probability, rather than certainty. The author is of the opinion that at some point the two terms become interchangeable....

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Medika Life -
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

A Pig Heart Was Transplanted Into a Human a Few Days Ago Is This The Future of Organ Transplantation?

Stephen Schimpff, MD MACP -
It is still a very experimental procedure, but it likely will be improved rapidly in the coming years and may become the standard approach...

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories